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Introduction {#sec005}
============

Despite major advances in therapeutic and diagnostic options, mortality and morbidity associated with infective endocarditis (IE) has not decreased significantly in the past four decades \[[@pone.0189421.ref001]\]. This may be related to factors such as increased frequency of age-related valvular degeneration, prosthetic-valve surgery, and hospital-related infections that change the microbial flora and antibiotic susceptibility \[[@pone.0189421.ref001]--[@pone.0189421.ref004]\].

Classically, *Streptococci* have been the main causative microorganisms of IE. However, recent studies have shown a significant increase in frequency of *Staphylococcus aureus*, up to 30% of cases \[[@pone.0189421.ref001]\]. As recent IE treatment recommendations are significantly based on non-randomized studies and expert opinion \[[@pone.0189421.ref005], [@pone.0189421.ref006]\], empiric antibiotic therapy is usually applied based on local microbiological characteristics.

For this reason, it is essential to periodically update information about regional IE pathogen characteristics and antibiotic susceptibility profile. The aim of this study was to evaluate the microbiological characteristics as well as factors associated with increased in-hospital mortality in patients hospitalized for infective endocarditis at two tertiary care hospitals in South Vietnam.

Materials and methods {#sec006}
=====================

Study design {#sec007}
------------

This study was performed at Heart Institute and Tam Duc Hospital of Cardiology, which are tertiary care referral hospitals located in Ho Chi Minh City, South Vietnam, between 01/01/2005 to 12/31/2014. The hospital charts of patients admitted with a diagnosis of IE according to the modified Duke criteria \[[@pone.0189421.ref006], [@pone.0189421.ref007]\] were retrospectively reviewed. Patients with lack of microbiological results were excluded. A total of 189 consecutive patients with diagnosis of definite or probable IE were eligible for inclusion with 17 patients excluded from study because of lack of microbiologic data. This study was approved by the institutional review board (IRB) of Pham Ngoc Thach university of medicine as well as IRB of Heart Institute and Tam Duc Hospital of Cardiology. Informed consent was waived because of the retrospective nature of the study.

The following variables were collected for each patient:

Clinical background: age, sex, factors predisposing to infective endocarditis (valvular heart diseases, congenital heart diseases, prosthetic valve, pacemaker implantation, history of injection drug use), history of cardiac surgery, medical comorbidities (including diabetes, hypertension, chronic kidney disease and ischemic heart disease), clinical signs and symptoms and the presence of systemic embolic disease.

Abnormal l*ab*oratory data: acute renal failure (increase of serum creatinine \> 26.5 μmol/l within 48 hours), white blood cell count (WBC) \> 11.000 cells/L, C reactive protein (CRP) concentration \> 100 mg/l.

Findings on ECG: any rhythm other than sinus tachycardia (heart rate \> 100 beats/min).

Findings on echocardiography: location of visible vegetation, vegetation size, vegetation number, valve type, impaired left ventricular function (ejection fraction \< 40%), congenital heart diseases, intracardiac complications of infective endocarditis.

Statistical analysis {#sec008}
--------------------

Continuous variables are expressed as mean **±** standard deviation (SD) for normal distributions and median + interquartile range for non-normal distributions. Categorical variables were represented as frequencies and percentages. For the evaluation of qualitative variables, we used the Chi-Square test. To test for significant differences between continuous variables in two groups, independent sample t-tests were performed. The patient variables that were analyzed in the univariate analysis included age, gender, valve type, heart failure, systemic emboli, conduction abnormalities, congenital heart diseases, WBC, CRP, acute renal failure, vegetation site, vegetation size, ejection fraction, intracardiac complications, positive blood culture, *Staphylococcus aureus* infection. Logistic regression analysis was performed to identify independent prognostic factors for death. \[[@pone.0189421.ref008]\]. Statistical analysis was performed using the SPSS 22 software program (SPSS Inc., Chicago, IL, USA). A p value of \< 0.05 was considered statistically significant.

Results {#sec009}
=======

Baseline characteristics {#sec010}
------------------------

During this 10-year period, a total of 189 consecutive patients with diagnosis of definite or probable IE were identified ([S1 File](#pone.0189421.s001){ref-type="supplementary-material"}). Baseline characteristics, predisposing conditions, clinical findings on admission for the 189 IE cases are shown in [Table 1](#pone.0189421.t001){ref-type="table"}. The mean age of patients was 37.6 ± 18.0 years with 120 men (63.5%) and 69 women (36.5%).

10.1371/journal.pone.0189421.t001

###### Characteristics of study sample.

![](pone.0189421.t001){#pone.0189421.t001g}

  Features                            n (%)        Features                                 n (%)
  ----------------------------------- ------------ ---------------------------------------- ---------------
  Valvular heart diseases             125 (66.1)   Fever                                    168 (88.9)
  Congenital heart diseases           36 (19.1)    Fever duration (days) before admission   26.69 ± 24.64
  Prosthetic valve                    24 (12.7)    Rigors                                   15 (7.9)
  Pacemakers implantation             4 (2.1)      Dyspnea                                  66 (34.9)
  History of cardiac surgery          33 (17.5)    Anorexia                                 10 (5.3)
  History of infective endocarditis   12 (6.3)     Weight loss                              12 (6.3)
  Intravenous drug user               2 (1.1)      Fatigue                                  46 (24.3)
  Previous antibiotic usage           46 (24.3)    Cardiac murmur                           115 (60.8)
  Hypertension                        21 (11.1)    Hepatomegaly                             21 (11.1)
  Diabetes                            2 (1.1)      Splenomegaly                             6 (3.2)
  Chronic kidney disease              2 (1.1)      Roth spot                                6 (3.2)
  Ischemic heart disease              3 (1.6)      Osler's node                             1 (0.5)
                                                   Skin rash                                4 (2.1)
                                                   Embolisms                                19 (10.1)
                                                   Cardiac conduction disorder              7 (3.7)

Categorical variables are presented as n (%)

33 patients (17.5%) had a history of cardiac surgery while 2 patients (1.1%) had a history of intravenous drug abuse. Only 2 patients (1.1%) had diabetes while none had end-stage renal disease. Predisposing valvular heart disease was found in 125 (66.1%) and congenital heart diseases in 36 (19.1%) of the patients. Prosthetic cardiac valves were present in 24 (12.7%) and 4 (2.1%) patients experienced pacemaker lead IE ([Table 1](#pone.0189421.t001){ref-type="table"}).

In our study, vegetation was observed in 172 cases (91%), of whom 14 (7.4%) were found to have large vegetation (\>15 mm). Affected valves were mitral valve in 78 (41.3%), aortic valve in 38 (20.1%), mitral and aortic valves in 11 (5.8%), tricuspid valve in 8 (4.2%) patients, pulmonary valve in 6 (3.2%) patients and right ventricular wall in 15 (7.9%) patients. Other vegetation sites were observed in 16 patients (8.5%) ([Table 2](#pone.0189421.t002){ref-type="table"}).

10.1371/journal.pone.0189421.t002

###### Echocardiographic findings of the study sample.

![](pone.0189421.t002){#pone.0189421.t002g}

  -------------------------------- ------------ ------------------------------- -----------
  **Vegetation number**            **n (%)**    **Vegetation site**             **n (%)**
      0                            17 (9.0)     Mitral                          78 (41.3)
      1                            87 (46.0)    Aortic                          38 (20.1)
  2                                46 (24.3)    Mitral and aortic               11 (5.8)
  ≥ 3                              39 (20.7)    Tricuspid                       8 (4.2)
  **Vegetation size**              **n (%)**    Pulmonary                       6 (3.2)
  ≤ 10mm                           116 (61.4)   Tricuspid and pulmonary valve   2 (1.1)
      10-15mm                      59 (31.2)    Left and right sides            5 (2.6)
      \>15mm                       14 (7.4)     Right ventricular wall          15 (7.9)
  **Intracardiac complications**   **n (%)**    Pulmonary arterial wall         6 (3.2)
  Valve leaflet perforation        41 (62.1)    Left ventricular wall           1 (0.5)
  Chordae tendinae rupture         20 (30.3)    Pacemaker wire                  2 (1.1)
  Paravalvular abscess             19 (28.8)    No vegetation                   17 (9.0)
  Prosthetic valve dehiscence      3 (4.5)                                      
  -------------------------------- ------------ ------------------------------- -----------

Categorical variables are presented as n (%)

Microbiological data {#sec011}
--------------------

Blood cultures were performed in all patients, with a positive rate of 70.4% (133 patients). There was a significant difference in positive culture rate between patients with or without prior antibiotic use before admission (50% and 76.9%, respectively; p = 0.001). *Streptococci* remained the most common causative agent of IE (75.2%), with Staphylococcal species identified in 13 patients (9.8%). Eleven of these 13 patients had *Staphylococcus aureus* ([Table 3](#pone.0189421.t003){ref-type="table"}).

10.1371/journal.pone.0189421.t003

###### Causative microorganisms of 133 cases of culture positive infective endocarditis.

![](pone.0189421.t003){#pone.0189421.t003g}

  Pathogens                        Cases (n)   (%)
  -------------------------------- ----------- ------
  *Streptococci*                   100         75.2
  Viridans group *Streptococci*    91          68.4
  Other *Streptococci*             9           6.8
  *Staphylococci*                  13          9.8
  *Staphylococcus aureus*          11          
  *Staphylococcus epidermidis*     2           
  *Enterococcus faecalis*          5           3.8
  Gram negative bacteria           6           4.5
  *Pseudomonase aeruginosa*        2           
  *Stenotrophomonas maltophilia*   1           
  *Burkholderia cepacia*           2           
  *Acinetobacter baumani*          1           
  Anerobic bacteria                2           1.5
  *Gemella hemolysans*             1           
  *Gemella morbillorum*            1           
  Other agents                     4           3.0
  *Chryseobacterium indologenes*   1           
  *Granulicatella adiacens*        1           
  *Haemophilus influenzae*         1           
  *Weeksella virosa*               1           
  *Candida* spp.                   3           2.2

Categorical variables are presented as n (%)

Over the three time periods examined, no significant changes were observed regarding infectious endocarditis microbiology (p = 0.059) apart from an increased frequency of Staphylococcal infection in the last period (18.2% versus 4.7% and 2.9%) ([Table 4](#pone.0189421.t004){ref-type="table"}). The data showed no statistically significant differences regarding the causative pathogens rate between the groups of patients having early and late infective endocarditis (p = 0.1). However, there was a higher rate of Staphylococcal infection in patients having prosthetic valve compared to native valve (16.7% versus 9.1%, P = 0.01) ([Table 4](#pone.0189421.t004){ref-type="table"}). Methicillin-resistant *staphylococcus aureus* (MRSA) accounted for 40% of *Staphylococcus aureus*. Streptococcal species were sensitive to ceftriaxone, ampicillin and vancomycin in 100% of cases; they were sensitive to penicillin 92.7% of the cases.

10.1371/journal.pone.0189421.t004

###### Causative microorganisms over the three time periods.

![](pone.0189421.t004){#pone.0189421.t004g}

  Causative microorganisms   Valve nature   Time to IE   Vegetation site   Period                                                      
  -------------------------- -------------- ------------ ----------------- --------- --------- --------- --------- --------- --------- ----
  *Streptococci*             94             6            2                 7         67        22        2         31        34        35
  (77.7)                     \(50\)         (18.2)       (77.8)            (82.7)    (64.7)    \(40\)    (88.6)    (79.1)    (63.6)    
  *Staphylococci*            11             2            4                 1         4         6         1         1         2         10
  (9.1)                      (16.7)         (36.4)       (11.1)            (4.9)     (17.6)    \(20\)    (2.9)     (4.7)     (18.2)    
  Gram negative bacilli      4              2            2                 0         4         1         0         0         4         2
  (3.3)                      (16.7)         (18.2)       \(0\)             (4.9)     (2.9)     \(0\)     \(0\)     (9.3)     (3.6)     
  Other bacteria             11             0            1                 0         4         4         2         2         2         7
  (9.1)                      \(0\)          (9.0)        \(0\)             (4.9)     (11.8)    \(40\)    (5.7)     (4.7)     (12.7)    
  Candida spp.               1              2            2                 1         2         1         0         1         1         1
  (0.8)                      (16.7)         (18.2)       (11.1)            (2.5)     (2.9)     \(0\)     (2.9)     (2.3)     (1.8)     
  Total                      121            12           11                9         81        34        5         35        43        55
  \(100\)                    \(100\)        \(100\)      \(100\)           \(100\)   \(100\)   \(100\)   \(100\)   \(100\)   \(100\)   

In-hospital mortality and predictive factors {#sec012}
--------------------------------------------

Thirteen of 189 patients died (6.9%) during their hospital stay. In the univariate analysis, risk factors that increased mortality were: prosthetic valve involvement, severe heart failure (NYHA classification 3 or 4), systemic emboli complication, conduction abnormalities, acute renal failure, vegetation size \> 15 mm, intracardiac complications, undefined microorganism by blood culture ([Table 5](#pone.0189421.t005){ref-type="table"}). While, prosthetic valve involvement (OR = 34.97, P = 0.006) and severe heart failure (NYHA 3, 4) (OR = 21.91, P = 0.01), vegetation size \> 15 mm (OR = 23.29, p = 0.029) were important independent risk factors for mortality in adjusted analysis.

10.1371/journal.pone.0189421.t005

###### Factors associated with in-hospital mortality, unadjusted.

![](pone.0189421.t005){#pone.0189421.t005g}

  Factor                       Category       Number      Deaths (%)   OR   95% CI         P value
  ---------------------------- -------------- ----------- ------------ ---- -------------- ----------
  Age (years)                  \<55           146         10 (6.8)     1    0.27--3.89     0.977
  ≥55                          43             3 (7.0)     1.02                             
  Gender                       Female         69          2 (2.9)      1    0.73--15.72    0.120
  Male                         120            11 (9.2)    3.38                             
  Valve type                   Native valve   165         7 (4.2)      1    2.28--24.84    0.001
  Prosthetic valve             24             6 (25)      7.52                             
  Heart failure grade          NYHA ≤ 2       142         3 (2.1)      1    3.28--47.83    \<0.0001
  NYHA 3, 4                    47             10 (21.3)   12.52                            
  Systemic emboli              No             175         9 (5.1)      1    1.93--28.16    0.003
  Yes                          14             4 (28.6)    7.38                             
  Conduction abnormalities     No             182         10 (5.5)     1    2.54--65.65    0.002
  Yes                          7              3 (42.9)    12.9                             
  Congenital heart disease     No             153         11 (7.2)     1    0.16--3.59     0.728
  Yes                          36             2 (5.6)     0.76                             
  Elevated leucocyte count     No             86          4 (4.7)      1    0.58--6.61     0.276
  Yes                          103            9 (8.7)     1.96                             
  Elevated CRP                 No             141         9 (6.4)      1    0.41--4.77     0.594
  Yes                          46             4 (8.7)     1.4                              
  Acute renal failure          No             159         8 (5.0)      1    1.14--12.47    0.029
  Yes                          30             5 (16.7)    3.78                             
  Vegetation size              ≤ 15 mm        175         9 (5.1)      1    1.93--28.16    0.003
  \>15 mm                      14             4 (28.6)    7.38                             
  Vegetation site              Pure left IE   128         8 (6.2)      1    0.17--3.99     0.796
  Pure right IE                39             2 (5.1)     0.81                             
  Ejection fraction            ≥ 40%          182         12 (6.6)     1    0.83--240.77   0.067
  \< 40%                       2              1 (50)      14.17                            
  Intracardiac complications   No             122         3 (2.5)      1    1.84--26.27    0.004
  Yes                          67             10 (14.9)   6.96                             
  Blood culture                Positive       133         5 (3.8)      1    1.33--13.69    0.015
  Negative                     56             8 (14.3)    4.27                             
  Staphylococcus aureus        No             178         12 (6.7)     1    0.16--11.73    0.766
  Yes                          11             1 (9.1)     1.38                             

Categorical variables are presented as n (%); OR: odds ratio; CI: confidence interval

Discussion {#sec013}
==========

The mean age of patients in our study was 37.6 ± 18.0 years. Published studies from developing countries also reported that patients with IE were mostly young \[[@pone.0189421.ref009]--[@pone.0189421.ref011]\]. Letaief *et al* reported on the epidemiology of infective endocarditis in Tunisia, showing a mean age of 32.4 ± 16.8 years \[[@pone.0189421.ref011]\]. This is contrast to data from developed countries which consistently report an older population with IE (median age 57.9 (IQR 43.2--71.8) years) \[[@pone.0189421.ref002]\]. This may be explained by high prevalence of rheumatic heart disease in Vietnam, whereas degenerative valve disease was the most common form of valvular disease in developed countries \[[@pone.0189421.ref002]\]. A Turkish study showed that the main factor contributing to younger patient age in IE could be the higher rate of rheumatic heart disease \[[@pone.0189421.ref012]\]. Mirabel *et al* studied infective endocarditis in the Lao PDR found patients with IE were mostly younger, and the most predisposing condition was rheumatic heart disease \[[@pone.0189421.ref009]\].

Echocardiography plays a key role in the diagnosis of IE. It is very useful to identify vegetations associated with IE as well as the assessment of complications of the disease. TEE is superior to TTE for detection of valvular vegetation as well as cardiac complications such as abscess, valvular leaflet perforation, chordae tendinae rupture and pseudoaneurysm \[[@pone.0189421.ref013], [@pone.0189421.ref014]\]. In our study, the vegetation rate was found up to 91%. Regarding to vegetation site, mitral valve was the most commonly affected valve, followed by the aortic valve, which is similar to the reports from the previous study \[[@pone.0189421.ref015]\].

The culture positive rate was 70.4%. This rate is higher than many studies from other developing countries \[[@pone.0189421.ref009], [@pone.0189421.ref010]\] but remains lower than those from developed countries \[[@pone.0189421.ref016], [@pone.0189421.ref017]\]. The high negative blood culture in our study can be explained by patients' self-medication with antibiotics, which is common in Vietnam \[[@pone.0189421.ref018]--[@pone.0189421.ref020]\]. In addition, detection of fastidious organisms is challenging with the use of conventional blood culture techniques, as isolation of these organisms requires special media or cell culture conditions. In addition, we lacked other techniques used to diagnose the pathogens of culture negative IE such as serological analysis for *Coxiella burnetii* and *Bartonella* species, polymerized chain reaction assays for *T*. *whipplei* or *Bartonella* and ribosomal RNA PCR assays on valvular specimens \[[@pone.0189421.ref021]\].

Under these conditions, our findings showed the most frequent causative microorganism to be *Streptococci* (75.2%), *Staphylococci* (9.8%), and gram negative bacilli (4.5%). With regard to the microbiology of IE over the three time periods, no significant changes were observed regarding infectious endocarditis microbiology, although there has been an increasing frequency of Staphylococcal species. The high prevalence of Streptococcal species in our study differs from the high rates of Staphylococcal infection noted in recent studies from the developed world \[[@pone.0189421.ref002], [@pone.0189421.ref016], [@pone.0189421.ref017]\]. There are several reasons for this discrepancy. First, the patients in this study had a lower mean age and a higher prevalence of rheumatic heart disease, however they had lower rates of persistent bacteremia, hemodialysis, diabetes, and intravascular devices, which are key risk factors associated with IE due to *Staphylococcus aureus* \[[@pone.0189421.ref022]\]. Second, the oral health status of the Vietnamese population is sub-optimal \[[@pone.0189421.ref023], [@pone.0189421.ref024]\], which is a key predisposing cause of IE. That could also explain why *Streptococci*, especially viridans group *Streptococci* was the most common observed pathogen. Finally, prosthetic valve prevalence, intravenous line-related IE and injection drug abuse was low compared with other studies.

Antimicrobial resistance was not a major problem among the microorganisms isolated from community-acquired endocarditis in our study. All *Streptococci* were sensitive to ampicillin, ceftriaxone, and vancomycin, while there was a mildly reduced susceptibility to penicillin, consistent with the worldwide increase in penicillin resistant viridans group *Streptococci*. For *Staphylococci*, all isolates were susceptible to vancomycin and teicoplanin, but there was high rate of methicillin resistant *Staphylococcus aureus* (40%). We suspect that the higher rate of methicillin resistance in our study reflects in part the widespread consumption of antimicrobials in the community in Vietnam, although this is consistent with the increased rate of methicillin resistance observed worldwide.

Our study shows in-hospital mortality rate of 6.9%, which is lower than previous reports \[[@pone.0189421.ref002], [@pone.0189421.ref025], [@pone.0189421.ref026]\]. The characteristic of our study sample which includes mostly younger patients affected by Streptococcal infections with lower rate of comorbidities likely explains the low observed mortality. Indeed, viridans Streptococcal IE has been documented as having a good prognosis versus other pathogens \[[@pone.0189421.ref002]\], as well as younger age \[[@pone.0189421.ref002], [@pone.0189421.ref026]\]. In our study, several factors were associated with in-hospital mortality, including moderate or severe heart failure, prosthetic valve involvement, systemic emboli complication, conduction abnormalities, vegetation length, intracardiac complication and negative blood culture. The strong predictors were prosthetic valve involvement, moderate or severe heart failure, vegetation size \> 15 mm. Congestive heart failure has been repeatedly reported as the common cause of death in infective endocarditis \[[@pone.0189421.ref027]--[@pone.0189421.ref029]\]. Prosthetic valve involvement and vegetation length \> 15 mm were also associated with mortality in previous studies \[[@pone.0189421.ref010], [@pone.0189421.ref027]\]. Published studies have found other predictors of mortality. Hasbun et al found abnormal mental status, moderate to severe heart failure, comorbidity, staphylococcal infection, and medical therapy without valve surgery were independent predictors for mortality at 6 months \[[@pone.0189421.ref028]\]. In addition, Thuny et al showed that clinical indicies such as age, female sex, creatinine serum \> 2mg/l, moderate or severe congestive heart failure, staphylococcal infection and vegetation length \> 15 mm were strong predictor of 1-year mortality \[[@pone.0189421.ref027]\].

In conclusion, in this Vietnamese population in recent years, streptococcal species were the major pathogen associated with IE with low rates of observed antimicrobial resistance. Prosthetic valve involvement, moderate or severe heart failure and vegetation size \> 15 mm were the most important independent predictors for in-hospital mortality in IE.

Study limitations {#sec014}
=================

The main limitation of this study is that the data were collected from only 2 tertiary care hospitals. Other than the relatively small sample size, there may also be a referral bias, and we cannot conclude patients with IE in the broader communities of Vietnam. The relatively low frequency of injection drug use may be due to reporting bias. We also cannot exclude selection bias, that is that the most severe cases of IE died before diagnosis and transport to our hospitals. The risk factors for in-hospital mortaliy may not be reliable due to the low mortality rate, which leads to wide 95% confidence interval. Finally, the retrospective study design does not allow rigorous long term follow up of patients.
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